Table 1.
Baseline clinical characteristics of 403 HBV-infected patients.
| Non-MASLD | MASLD | P-value | |
|---|---|---|---|
| Age | 39.26 ± 9.05 | 43.52 ± 9.31 | <0.001 |
| Sex, n (%) | <0.001 | ||
| Female | 145 (64.16%) | 69 (38.98%) | |
| Male | 81 (35.84%) | 108 (61.02%) | |
| BMI | 21.21 ± 2.52 | 24.27 ± 2.64 | <0.001 |
| HBV DNA (log IU/mL) | 5.62 ± 2.30 | 4.90 ± 2.14 | 0.002 |
| PLT | 211.67 ± 61.13 | 215.46 ± 57.58 | 0.527 |
| TBL | 11.94 ± 6.08 | 10.81 ± 4.89 | 0.046 |
| AST | 26.84 ± 10.61 | 27.94 ± 9.11 | 0.272 |
| ALT | 23.09 ± 8.42 | 27.89 ± 7.63 | <0.001 |
| GGT | 21.15 ± 15.32 | 28.17 ± 15.19 | <0.001 |
| Cholesterol | 4.88 ± 1.04 | 5.05 ± 1.06 | 0.109 |
| Triglycerides | 1.18 ± 0.87 | 1.73 ± 0.99 | <0.001 |
| HDL | 1.40 ± 0.33 | 1.16 ± 0.28 | <0.001 |
| HBeAg, n (%) | 0.013 | ||
| negative | 115 (50.88%) | 112 (63.28%) | |
| positive | 111 (49.12%) | 65 (36.72%) |
Data are presented as a mean value with SD.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; GGT, gamma-glutamyl transferase; HBV DNA, Hepatitis B virus-deoxyribonucleic acid; HBeAg, hepatitis B e antigen; HDL, high-density lipoprotein; MASLD, metabolic dysfunction-associated steatotic liver disease; PLT, platelet; TBL, total bilirubin.